Retreatment of Residual and Recurrent Aneurysms After Embolization With the Woven EndoBridge Device: Multicenter Case Series.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The Woven EndoBridge (WEB) device (Terumno Corp. [parent company of Microvention]) was approved by the U.S. Food and Drug Administration as the first intrasaccular device for intracranial aneurysm treatment in December 2018. Its use has become more common since then, but both trial results and postmarket experiences have raised questions about the efficacy in achieving complete aneurysm obliteration. Retreatment after WEB embolization has not been extensively discussed.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Neurosurgery

Title: Neurosurgery

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1524-4040

ISSN (Print): 0148-396X

Publication date (Electronic): May 01 2022

Volume: 90

Issue: 5

Affiliations

[1 ] Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA.

[2 ] Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

[3 ] NeuroInterventional Program, Massachusetts General Hospital, Boston, Massachusetts, USA.

[4 ] Department of Neurological Surgery, Jacobs School of Medicine at Biomedical Sciences, Buffalo, New York, USA.

[5 ] Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.

[6 ] Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.

[7 ] Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, Pennsylvania, USA.

[8 ] Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

[9 ] Department of Neurosurgery, University of Miami, Miami, Florida, USA.

[10 ] Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

[11 ] Department of Neurosurgery, Geisinger, Danville, Pennsylvania, USA.

[12 ] Department of Neurosurgery, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, Austria, USA.

[13 ] Yashar Neurosurgery, Los Angeles, California, USA.

[14 ] Lyerly Neurosurgery, Baptist Neurological Institute, Jacksonville, Florida, USA.

[15 ] Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

[16 ] Department of Neurosurgery, University of Texas Medical Branch, Galveston, Texas, USA.

Article

Publisher Item ID: 00006123-202205000-00011

DOI: 10.1227/neu.0000000000001883

PMC ID: 9524592

PubMed ID: 35244028

SO-VID: 34334e44-466b-4af7-9878-410ce8c1b27a

History

Data availability:

Comments

Comment on this article

scite_

Cited by 7

See all cited by